Hong Kong: Hong Kong has identified the Hyderabad-based pharmaceutical company Bharat Biotech’s vaccine Covid Covaxin on the list of 19 approved.
With this, a total of 96 countries have recognized Covaxin and Covishield.
Both vaccines Covid-19 has also been given a list of emergency use (Eul) of the World Health Organization (WHO).
Canada, the US, Australia, Spain, England, France, Germany, Belgium, Russia, and Switzerland, is among 96 countries that have been given approval from the Indian vaccine produced.
Last week, which gave approval for emergency use Covaxin list and Bharat Biotech said that the vaccine was found to have 78 percent efficacy against covid-19 severity, 14 days or more after the second dose.
“Covaxin found to have a 78 percent efficacy against Covid 19th of each severity, 14 days or more after the second dose, and is suitable for low-income countries and middle for easy storage requirements,” said who is to say.
Procedures for recording emergency use UN Emergency UN body assessing the vaccine according to the procedure based on a review of data on quality, safety, efficacy, and compliance risk management plans in countries of low and middle income.
Hong Kong Approved Covaxin Bharat Biotech
